The correlation between clinical, nuclear and histologic findings in a patient with Von Recklinghausen's disease

Justus Martijn Brinkman, Johannes L. Bron, Paul I J M Wuisman, Paul J. van Diest, Emile F I Comans, Carla F M Molthoff

Research output: Contribution to journalArticle

Abstract

Background: Malignant peripheral nerve sheath tumours (MPNST) are known to develop in patients with Neurofibromatosis type I (NF1) resulting in a decreased overall survival. The association between NF1 and the development of such MPNST has been investigated in detail. The biological behaviour however of multiple disseminated neurofibromas in patients with NF1 and the risk factors for malignant transformation remain unknown. Clinical signs are unreliable and additional imaging techniques are therefore required. Of such, positron emission tomography using [18F]-2-fluoro-2-deoxy-D-glucose (18FDG PET) is used to detect malignant changes in neurofibromas. Case presentation: A case is presented of a patient suffering from NF1 with clinical signs of malignant change and accumulation of 18FDG in multiple neurofibromas. Histopathological examination of 20 lesions however, did not reveal any malignant features. There was no statistically significant relation between 18FDG accumulation and malignant change, but rather with pain, size and growth. Conclusion: This case adds to the knowledge of the diverse biological behaviour of neurofibromas in patients with NF1

Original languageEnglish (US)
Article number130
JournalWorld Journal of Surgical Oncology
Volume5
DOIs
StatePublished - Nov 12 2007
Externally publishedYes

Fingerprint

Neurofibromatosis 1
Fluorodeoxyglucose F18
Neurofibroma
Neurofibromatoses
Neurilemmoma
Positron-Emission Tomography
Pain
Survival
Growth

ASJC Scopus subject areas

  • Cancer Research
  • Surgery

Cite this

Brinkman, J. M., Bron, J. L., Wuisman, P. I. J. M., van Diest, P. J., Comans, E. F. I., & Molthoff, C. F. M. (2007). The correlation between clinical, nuclear and histologic findings in a patient with Von Recklinghausen's disease. World Journal of Surgical Oncology, 5, [130]. https://doi.org/10.1186/1477-7819-5-130

The correlation between clinical, nuclear and histologic findings in a patient with Von Recklinghausen's disease. / Brinkman, Justus Martijn; Bron, Johannes L.; Wuisman, Paul I J M; van Diest, Paul J.; Comans, Emile F I; Molthoff, Carla F M.

In: World Journal of Surgical Oncology, Vol. 5, 130, 12.11.2007.

Research output: Contribution to journalArticle

Brinkman, Justus Martijn ; Bron, Johannes L. ; Wuisman, Paul I J M ; van Diest, Paul J. ; Comans, Emile F I ; Molthoff, Carla F M. / The correlation between clinical, nuclear and histologic findings in a patient with Von Recklinghausen's disease. In: World Journal of Surgical Oncology. 2007 ; Vol. 5.
@article{1601bdfbe3f74c9f8f422bdf65ab7e92,
title = "The correlation between clinical, nuclear and histologic findings in a patient with Von Recklinghausen's disease",
abstract = "Background: Malignant peripheral nerve sheath tumours (MPNST) are known to develop in patients with Neurofibromatosis type I (NF1) resulting in a decreased overall survival. The association between NF1 and the development of such MPNST has been investigated in detail. The biological behaviour however of multiple disseminated neurofibromas in patients with NF1 and the risk factors for malignant transformation remain unknown. Clinical signs are unreliable and additional imaging techniques are therefore required. Of such, positron emission tomography using [18F]-2-fluoro-2-deoxy-D-glucose (18FDG PET) is used to detect malignant changes in neurofibromas. Case presentation: A case is presented of a patient suffering from NF1 with clinical signs of malignant change and accumulation of 18FDG in multiple neurofibromas. Histopathological examination of 20 lesions however, did not reveal any malignant features. There was no statistically significant relation between 18FDG accumulation and malignant change, but rather with pain, size and growth. Conclusion: This case adds to the knowledge of the diverse biological behaviour of neurofibromas in patients with NF1",
author = "Brinkman, {Justus Martijn} and Bron, {Johannes L.} and Wuisman, {Paul I J M} and {van Diest}, {Paul J.} and Comans, {Emile F I} and Molthoff, {Carla F M}",
year = "2007",
month = "11",
day = "12",
doi = "10.1186/1477-7819-5-130",
language = "English (US)",
volume = "5",
journal = "World Journal of Surgical Oncology",
issn = "1477-7819",
publisher = "BioMed Central",

}

TY - JOUR

T1 - The correlation between clinical, nuclear and histologic findings in a patient with Von Recklinghausen's disease

AU - Brinkman, Justus Martijn

AU - Bron, Johannes L.

AU - Wuisman, Paul I J M

AU - van Diest, Paul J.

AU - Comans, Emile F I

AU - Molthoff, Carla F M

PY - 2007/11/12

Y1 - 2007/11/12

N2 - Background: Malignant peripheral nerve sheath tumours (MPNST) are known to develop in patients with Neurofibromatosis type I (NF1) resulting in a decreased overall survival. The association between NF1 and the development of such MPNST has been investigated in detail. The biological behaviour however of multiple disseminated neurofibromas in patients with NF1 and the risk factors for malignant transformation remain unknown. Clinical signs are unreliable and additional imaging techniques are therefore required. Of such, positron emission tomography using [18F]-2-fluoro-2-deoxy-D-glucose (18FDG PET) is used to detect malignant changes in neurofibromas. Case presentation: A case is presented of a patient suffering from NF1 with clinical signs of malignant change and accumulation of 18FDG in multiple neurofibromas. Histopathological examination of 20 lesions however, did not reveal any malignant features. There was no statistically significant relation between 18FDG accumulation and malignant change, but rather with pain, size and growth. Conclusion: This case adds to the knowledge of the diverse biological behaviour of neurofibromas in patients with NF1

AB - Background: Malignant peripheral nerve sheath tumours (MPNST) are known to develop in patients with Neurofibromatosis type I (NF1) resulting in a decreased overall survival. The association between NF1 and the development of such MPNST has been investigated in detail. The biological behaviour however of multiple disseminated neurofibromas in patients with NF1 and the risk factors for malignant transformation remain unknown. Clinical signs are unreliable and additional imaging techniques are therefore required. Of such, positron emission tomography using [18F]-2-fluoro-2-deoxy-D-glucose (18FDG PET) is used to detect malignant changes in neurofibromas. Case presentation: A case is presented of a patient suffering from NF1 with clinical signs of malignant change and accumulation of 18FDG in multiple neurofibromas. Histopathological examination of 20 lesions however, did not reveal any malignant features. There was no statistically significant relation between 18FDG accumulation and malignant change, but rather with pain, size and growth. Conclusion: This case adds to the knowledge of the diverse biological behaviour of neurofibromas in patients with NF1

UR - http://www.scopus.com/inward/record.url?scp=38049128728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38049128728&partnerID=8YFLogxK

U2 - 10.1186/1477-7819-5-130

DO - 10.1186/1477-7819-5-130

M3 - Article

C2 - 17997819

AN - SCOPUS:38049128728

VL - 5

JO - World Journal of Surgical Oncology

JF - World Journal of Surgical Oncology

SN - 1477-7819

M1 - 130

ER -